INHALON BIOPHARMA, INC. — United States · Federal contract register · Supplier record: 2 contracts, all years ($5,410,293 · Sep 2024 – Sep 2025); $5.4M since January 2024 (2 contracts · 1 agency); 34th rank in the line (of 102 suppliers · 0.56%); 3 agencies never served ($516M on the line without INHALON BIOPHARMA, INC.).
Assay record ASY-US-0YGVY0K0LI · Cite as: Assay Systems, “INHALON BIOPHARMA, INC. in the USAspending register”, https://assay-systems.com/register/us/inhalon-biopharma-inc/
2
contracts, all years
$5,410,293 · Sep 2024 – Sep 2025
$5.4M
since January 2024
2 contracts · 1 agency
34th
rank in the line
of 102 suppliers · 0.56%
3
agencies never served
$516M on the line without INHALON BIOPHARMA, INC.
Own record by year
2024 onward
$2.2M
$3.2M
202420252026
Who buys from INHALON BIOPHARMA, INC.
since January 2024
1agencies
$5.4Mpaid
100.0%top buyer
Department of Defense100.0%
$5,410,293
The line
since January 2024
$566Mline value
124contracts
4agencies
102suppliers
70.3%held by top ten
Health r&d services; health care services; experimental development (AN13)
$239M
$109M
$218M
202420252026Jan–Sep
34thof 102 suppliers
$3,175,643INHALON BIOPHARMA, INC. in the line
0.56%share of the line
6.3%of $50,693,667 spent by Department of Defense
Agencies that buy the line and never bought from INHALON BIOPHARMA, INC.
3agencies
106contracts
$515,561,760since January 2024
Department of Health and Human Services63 contracts
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.